BSG and neoplasm: EMMPRIN has been characterized as an important inducer of MMP in tumor tissues [20,54], but has no effects on their physiological inhibitors (tissue inhibitor for MMP-1 and -2; TIMP-1 or -2), therefore modifying the balance among MMP production and activation.